GT Medical Technologies
Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors
$100MSeries E
Role not disclosedGH
Gilde Healthcare
Activity from announced rounds
Activity in this selectionSeries C+
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $255M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionAdcendo
Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.
$75MSeries C
Role not disclosedEndovascular Engineering
Develops thrombectomy systems for venous thromboembolism treatment
$80MSeries C
Role not disclosed